<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>25(3)</volume><submitter>Tsuda B</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Historically, humoral immunity was considered unimportant in anti-tumor immunity, and the differentiation and anti-tumor activity of B cells in breast cancer are poorly understood. However, it was recently discovered that B cells participate in tumor immunity through both antibody production and immunosuppressive mechanisms. We analyzed the expression of B-cell differentiation markers in detail using fluorescence-activated cell sorting to investigate the relationship between B-cell subsets and breast cancer etiology.&lt;h4>Methods&lt;/h4>Blood samples were taken from breast cancer patients and healthy donors, and peripheral blood mononuclear cells were collected. B cells at various stages of differentiation were identified by the expression of combinations of the cell surface </pubmed_abstract><journal>Breast cancer (Tokyo, Japan)</journal><pagination>284-291</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5906508</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>B-cell populations are expanded in breast cancer patients compared with healthy controls.</pubmed_title><pmcid>PMC5906508</pmcid><pubmed_authors>Miyamoto A</pubmed_authors><pubmed_authors>Ogiya R</pubmed_authors><pubmed_authors>Terao M</pubmed_authors><pubmed_authors>Saito Y</pubmed_authors><pubmed_authors>Yokoyama K</pubmed_authors><pubmed_authors>Kametani Y</pubmed_authors><pubmed_authors>Okamura T</pubmed_authors><pubmed_authors>Niikura N</pubmed_authors><pubmed_authors>Tokuda Y</pubmed_authors><pubmed_authors>Oshitanai R</pubmed_authors><pubmed_authors>Suzuki Y</pubmed_authors><pubmed_authors>Morioka T</pubmed_authors><pubmed_authors>Miyako H</pubmed_authors><pubmed_authors>Tsuda B</pubmed_authors></additional><is_claimable>false</is_claimable><name>B-cell populations are expanded in breast cancer patients compared with healthy controls.</name><description>&lt;h4>Background&lt;/h4>Historically, humoral immunity was considered unimportant in anti-tumor immunity, and the differentiation and anti-tumor activity of B cells in breast cancer are poorly understood. However, it was recently discovered that B cells participate in tumor immunity through both antibody production and immunosuppressive mechanisms. We analyzed the expression of B-cell differentiation markers in detail using fluorescence-activated cell sorting to investigate the relationship between B-cell subsets and breast cancer etiology.&lt;h4>Methods&lt;/h4>Blood samples were taken from breast cancer patients and healthy donors, and peripheral blood mononuclear cells were collected. B cells at various stages of differentiation were identified by the expression of combinations of the cell surface </description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 May</publication><modification>2025-05-18T13:10:22.431Z</modification><creation>2025-05-18T13:10:22.431Z</creation></dates><accession>S-EPMC5906508</accession><cross_references><pubmed>29204848</pubmed><doi>10.1007/s12282-017-0824-6</doi></cross_references></HashMap>